Corruption in Pharmaceuticals – International Perspective 10 – Blog Post #504 by Asrar Qureshi

Corruption in Pharmaceuticals – International Perspective 10 – Blog Post #504 by Asrar Qureshi

Dear Colleagues!  This is Pharma Veterans Blog Post #504. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here.


Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank.

Six decision points were identified where corruption could infiltrate. The first was manufacturing, second was marketing authorization, third was selection, fourth was procurement, fifth was distribution, sixth was drug prescribing and dispensing.
Selected Strategies to Mitigate Corruption in Pharmaceutical Systems
The report goes on to make recommendations for certain strategies to mitigate the risk of corruption. It is more like an indicative list which can be modified for particular use.
The list is arranged as per the six decision points which are vulnerable to corruption. For greater relevance to our country situation, I have added the column of Pakistan Status.
[Quote]

 

Comments

Popular posts from this blog

Cannabis Based Drugs (CBDs) and A Brief History of Use of Cannabis sativa Part I – Blog Post by Asrar Qureshi

New Year 2024– Ideas For A Life Worth Living – Asrar Qureshi’s Blog Post #894

Pharmaceutical Industry Challenges Today – Asrar Qureshi’s Blog Post #822